Intro | Trades | EPS | Stock Quotes | Tenyear | F8 Twitter | Resources | Investing Articles | Z Twitter | Z Disqus


Author:
• Thursday, October 15th, 2009

My DRIV made 700% profit–wow!
UPDATE 10-20 BSX earnings weren’t that bad today, and yet the market does not like medical devices sector, because of the Obama health reform plan–cuts in medicare—so BSX is down -16%–I’m pretty sure STJ will be down on its earnings too. The market doesn’t care what is reported–
SRJ earnings 10-21

STJ at 32.5 prior to 10-21 earnings date–Go long into earnings
STJ shows strong EPS history.
St. Jude Medical, Inc. develops, manufactures, and distributes cardiovascular and implantable neurostimulation medical devices worldwide.

__
__
St. Jude Medical (STJ: NYSE) By Robert W. Baird ($38.24, Oct. 6, 2009)
WE ARE UPGRADING St. Jude Medical (ticker: STJ) to Outperform [from Neutral] with a $41 price target.

The selloff in St. Jude Medical to the $34 area reflects disappointment with the third quarter where currency-neutral revenue growth will be 10%.

Category: healthcare sector  | Tags:
You can follow any responses to this entry through the RSS 2.0 feed. You can leave a response, or trackback from your own site.

Viewing 20 Comments

blog comments powered by Disqus